Advertisement
JBC

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a Letter to Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hourcade, D. E.
Right arrow Articles by Oglesby, T. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hourcade, D. E.
Right arrow Articles by Oglesby, T. J.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Volume 270, Number 34, Issue of August 25, pp. 19716-19722, 1995
©1995 by The American Society for Biochemistry and Molecular Biology, Inc.
Analysis of the Short Consensus Repeats of Human Complement Factor B by Site-directed Mutagenesis

(Received for publication, February 27, 1995; and in revised form, June 8, 1995)

Dennis E. Hourcade Lynne M. Wagner Teresa J. Oglesby

Human factor B is required for the initiation and propagation of the complement alternative pathway. It also participates in the amplification of the complement classical pathway. Alone, factor B is a zymogen with little known biochemical activity, but in the context of the alternative pathway convertases, the factor B serine protease is activated in a process that first involves the association with C3b and subsequently the cleavage of factor B into two fragments, Ba and Bb. Ba, the NH(2)-terminal fragment, is composed mainly of three tandem short consensus repeats, globular domains found in other complement proteins. It dissociates from the convertase during assembly, leaving the active C3 convertase, C3bBb. Previous reports suggest that the Ba region may be instrumental in convertase assembly. This hypothesis was tested using site-directed mutagenesis of recombinant factor B and monoclonal antibody epitope mapping to evaluate the relative importance of specific short consensus repeat amino acid residues. Three sites of interest were identified. Site 1 is a stretch of 19 contiguous amino acids in short consensus repeat 1 that form the epitope of a monoclonal antibody that effectively blocks factor B function. Site 2, composed of 6 contiguous amino acids in short consensus repeat 2, and site 3, consisting of 7 contiguous amino acids in short consensus repeat 3, were defined by mutations that reduce factor B hemolytic activity to 3% or less. Further analyses indicated that sites 2 and 3 contribute to factor B-C3b interactions.




Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
Proc. Natl. Acad. Sci. USAHome page
E. Torreira, A. Tortajada, T. Montes, S. R. de Cordoba, and O. Llorca
3D structure of the C3bB complex provides insights into the activation and regulation of the complement alternative pathway convertase
PNAS, January 20, 2009; 106(3): 882 - 887.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
D. E. Hourcade
The Role of Properdin in the Assembly of the Alternative Pathway C3 Convertases of Complement
J. Biol. Chem., January 27, 2006; 281(4): 2128 - 2132.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
L. A. Kuttner-Kondo, M. P. Dybvig, L. M. Mitchell, N. Muqim, J. P. Atkinson, M. E. Medof, and D. E. Hourcade
A Corresponding Tyrosine Residue in the C2/Factor B Type A Domain Is a Hot Spot in the Decay Acceleration of the Complement C3 Convertases
J. Biol. Chem., December 26, 2003; 278(52): 52386 - 52391.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
Y. Xu, M. Ma, G. C. Ippolito, H. W. Schroeder Jr., M. C. Carroll, and J. E. Volanakis
Complement activation in factor D-deficient mice
PNAS, November 20, 2001; (2001) 261428398.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
M. Krych-Goldberg, R. E. Hauhart, V. B. Subramanian, B. M. Yurcisin II, D. L. Crimmins, D. E. Hourcade, and J. P. Atkinson
Decay Accelerating Activity of Complement Receptor Type 1 (CD35). TWO ACTIVE SITES ARE REQUIRED FOR DISSOCIATING C5 CONVERTASES
J. Biol. Chem., October 29, 1999; 274(44): 31160 - 31168.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
D. E. Hourcade, L. M. Mitchell, and T. J. Oglesby
Mutations of the Type A Domain of Complement Factor B That Promote High-Affinity C3b-Binding
J. Immunol., March 1, 1999; 162(5): 2906 - 2911.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
L. C. Smith, C.-S. Shih, and S. G. Dachenhausen
Coelomocytes Express SpBf, a Homologue of Factor B, the Second Component in the Sea Urchin Complement System
J. Immunol., December 15, 1998; 161(12): 6784 - 6793.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
D. E. Hourcade, L. M. Mitchell, and T. J. Oglesby
A Conserved Element in the Serine Protease Domain of Complement Factor B
J. Biol. Chem., October 2, 1998; 273(40): 25996 - 26000.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
D. E. Hourcade, L. Mitchell, L. A. Kuttner-Kondo, J. P. Atkinson, and M. E. Medof
Decay-accelerating Factor (DAF), Complement Receptor 1 (CR1), and Factor H Dissociate the Complement AP C3 Convertase (C3bBb) via Sites on the Type A Domain of Bb
J. Biol. Chem., January 4, 2002; 277(2): 1107 - 1112.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
Y. Xu, M. Ma, G. C. Ippolito, H. W. Schroeder Jr., M. C. Carroll, and J. E. Volanakis
Complement activation in factor D-deficient mice
PNAS, December 4, 2001; 98(25): 14577 - 14582.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 1995 by the American Society for Biochemistry and Molecular Biology.
Advertisement
spacer
Advertisement
Advertisement